Freestone Capital Holdings’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Sell |
54,305
-2,750
| -5% | -$571K | 0.33% | 48 |
|
|
2026
Q1 | $12.1M | Sell |
57,055
-1,994
| -3% | -$429K | 0.37% | 50 |
|
|
2025
Q4 | $12.1M | Buy |
59,049
+2,092
| +4% | +$394K | 0.36% | 44 |
|
|
2025
Q3 | $8.94M | Buy |
56,957
+1,030
| +2% | +$159K | 0.27% | 64 |
|
|
2025
Q2 | $9.4M | Sell |
55,927
-1,688
| -3% | -$251K | 0.32% | 57 |
|
|
2025
Q1 | $7.94M | Buy |
57,615
+1,971
| +4% | +$251K | 0.3% | 63 |
|
|
2024
Q4 | $6.58M | Sell |
55,644
-365
| -0.7% | -$42.6K | 0.23% | 71 |
|
|
2024
Q3 | $6.19M | Sell |
56,009
-265
| -0.5% | -$27.7K | 0.21% | 82 |
|
|
2024
Q2 | $5.53M | Buy |
56,274
+1,039
| +2% | +$106K | 0.2% | 75 |
|
|
2024
Q1 | $6.18M | Buy |
55,235
+333
| +0.6% | +$35.9K | 0.23% | 70 |
|
|
2023
Q4 | $5.53M | Sell |
54,902
-1,090
| -2% | -$108K | 0.25% | 71 |
|
|
2023
Q3 | $4.86M | Sell |
55,992
-7,741
| -12% | -$700K | 0.26% | 70 |
|
|
2023
Q2 | $6.03M | Sell |
63,733
-2,854
| -4% | -$241K | 0.24% | 67 |
|
|
2023
Q1 | $5.03M | Sell |
66,587
-3,723
| -5% | -$281K | 0.22% | 74 |
|
|
2022
Q4 | $5.4M | Sell |
70,310
-21,811
| -24% | -$1.66M | 0.25% | 67 |
|
|
2022
Q3 | $6.14M | Sell |
92,121
-24,225
| -21% | -$1.54M | 0.28% | 58 |
|
|
2022
Q2 | $6.08M | Sell |
116,346
-18,939
| -14% | -$1.08M | 0.23% | 70 |
|
|
2022
Q1 | $7.67M | Sell |
135,285
-1,439
| -1% | -$77.1K | 0.31% | 70 |
|
|
2021
Q4 | $7.04M | Sell |
136,724
-860
| -0.6% | -$42.2K | 0.3% | 72 |
|
|
2021
Q3 | $6.8M | Buy |
137,584
+5,293
| +4% | +$287K | 0.34% | 71 |
|
|
2021
Q2 | $7.55M | Buy |
132,291
+83
| +0.1% | +$4.85K | 0.38% | 66 |
|
|
2021
Q1 | $8.03M | Sell |
132,208
-2,314
| -2% | -$128K | 0.44% | 58 |
|
|
2020
Q4 | $7.21M | Buy |
134,522
+20,437
| +18% | +$1.06M | 0.42% | 62 |
|
|
2020
Q3 | $5.36M | Sell |
114,085
-2,905
| -2% | -$149K | 0.35% | 71 |
|
|
2020
Q2 | $6.11K | Buy |
116,990
+4,432
| +4% | +$228K | 0.07% | 65 |
|
|
2020
Q1 | $5.4K | Sell |
112,558
-16,444
| -13% | -$854K | 0.12% | 65 |
|
|
2019
Q4 | $6.53K | Sell |
129,002
-15,003
| -10% | -$775K | 0.14% | 50 |
|
|
2019
Q3 | $6.8K | Sell |
144,005
-28,507
| -17% | -$1.3M | 0.16% | 51 |
|
|
2019
Q2 | $8.13K | Buy |
172,512
+104,708
| +154% | +$4.83M | 0.21% | 41 |
|
|
2019
Q1 | $3.27M | Buy |
67,804
+4,191
| +7% | +$210K | 0.19% | 132 |
|
|
2018
Q4 | $2.84M | Sell |
63,613
-25,746
| -29% | -$1.34M | 0.19% | 130 |
|
|
2018
Q3 | $4.83M | Buy |
+89,359
| New | +$4.57M | 0.03% | 111 |
|
Other funds holding CAH
Freestone Capital Holdings's CAH Position: Q2 2026 in Review
Freestone Capital Holdings reduced its Cardinal Health (CAH) stake by 4.8% in Q2 2026, selling an estimated $571K and leaving 54,305 shares worth $12.9M. The position accounts for 0.33% of the portfolio, ranked #48.
Freestone Capital Holdings first reported a position in CAH in Q3 2018 and has held it in 32 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Freestone Capital Holdings held 54,305 shares of Cardinal Health worth $12.9M as of Q2 2026.
- Freestone Capital Holdings sold 2,750 Cardinal Health shares in Q2 2026, an estimated $571K.
- Cardinal Health made up 0.33% of Freestone Capital Holdings's portfolio in Q2 2026, its #48 holding.
- Freestone Capital Holdings first reported a position in Cardinal Health in Q3 2018 and has held it in 32 quarters since.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.